Login / Signup

Discrepancy in responses to dabrafenib plus trametinib combination therapy in intracranial and extracranial metastases in melanoma patients.

Tadahiro KobayashiSara MatsumotoKyoko ShimizuMiho MiyakeShintaro MaedaYasuhito HamaguchiTakashi Matsushita
Published in: The Journal of dermatology (2020)
Keyphrases
  • combination therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis